Ding-Feng Su Selected Research

Ketanserin

12/2016	Baroreflex deficiency aggravates atherosclerosis via α7 nicotinic acetylcholine receptor in mice.
12/2013	The protective action of ketanserin against lipopolysaccharide-induced shock in mice is mediated by inhibiting inducible NO synthase expression via the MEK/ERK pathway.
11/2011	Effects of ketanserin on endotoxic shock and baroreflex function in rodents.
11/2010	Effects of low-dose ketanserin on atherosclerosis in rats and rabbits.
1/2010	Blood pressure reduction combining baroreflex restoration for stroke prevention in hypertension in rats.
7/2003	Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ding-Feng Su Research Topics

Disease

16	Stroke (Strokes) 06/2021 - 10/2007
13	Inflammation (Inflammations) 01/2020 - 11/2003
12	Hypertension (High Blood Pressure) 06/2021 - 01/2003
8	Infarction (Infarctions) 03/2017 - 01/2010
8	Hypertrophy 03/2011 - 08/2002
7	Ischemic Stroke 01/2021 - 02/2011
6	Body Weight (Weight, Body) 01/2018 - 03/2004
6	Shock 11/2016 - 06/2004
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 09/2007
5	Brain Ischemia (Cerebral Ischemia) 01/2018 - 09/2007
5	Necrosis 09/2014 - 11/2003
4	Ischemia 09/2014 - 09/2007
4	Myocardial Infarction 08/2013 - 08/2003
4	Septic Shock (Toxic Shock Syndrome) 01/2011 - 06/2004
3	Fatigue 01/2018 - 01/2016
3	Colitis 01/2017 - 01/2016
3	Atherosclerosis 12/2016 - 11/2005
3	Obesity 01/2016 - 09/2010
3	AIDS-Related Complex (ARC) 01/2016 - 12/2003
3	Tachycardia (Tachyarrhythmias) 02/2011 - 02/2004
3	Hypotension (Low Blood Pressure) 02/2011 - 11/2003
3	Cardiomegaly (Heart Hypertrophy) 01/2010 - 03/2004
2	Brain Injuries (Brain Injury) 01/2020 - 12/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 01/2009
2	Hyperglycemia 01/2018 - 07/2017
2	Crush Syndrome 11/2016 - 01/2016
2	Insulin Resistance 01/2016 - 09/2010
2	Rheumatoid Arthritis 05/2014 - 02/2014
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2009 - 09/2002
2	Bradycardia 09/2007 - 11/2003
2	Cardiac Arrhythmias (Arrythmia) 04/2004 - 08/2003
2	Fibrosis (Cirrhosis) 11/2003 - 08/2002
1	Atherosclerotic Plaque (Atheroma) 11/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	COVID-19 01/2020
1	Bone Marrow Failure Disorders 05/2019

Drug/Important Bio-Agent (IBA)

7	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2017 - 08/2009
7	LipopolysaccharidesIBA 01/2017 - 06/2004
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2009
6	KetanserinIBA 12/2016 - 07/2003
5	CollagenIBA 11/2021 - 11/2003
5	Oxygen (Dioxygen)IBA 01/2021 - 05/2004
5	anisodamineIBA 01/2020 - 01/2011
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 11/2003
5	Messenger RNA (mRNA)IBA 01/2018 - 09/2008
5	CytokinesIBA 03/2017 - 08/2007
5	Insulin (Novolin)FDA Link 01/2016 - 08/2003
5	Nicotinamide PhosphoribosyltransferaseIBA 09/2014 - 09/2010
5	Angiotensin IIIBA 01/2011 - 08/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 12/2005
4	Orosomucoid (Seromucoid)IBA 11/2019 - 01/2016
4	InterleukinsIBA 11/2019 - 01/2008
4	Interleukin-6 (Interleukin 6)IBA 11/2019 - 01/2008
4	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 04/2009
4	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2016 - 01/2013
3	CholesterolIBA 11/2021 - 11/2005
3	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2021 - 08/2009
3	Sirtuin 1IBA 05/2019 - 01/2009
3	salicylhydroxamic acid (SHAM)IBA 12/2016 - 11/2005
3	Neostigmine (Neostigmine Bromide)IBA 11/2016 - 11/2012
3	Cholinergic ReceptorsIBA 05/2014 - 11/2012
3	Clonidine (ST 155)FDA LinkGeneric 10/2007 - 11/2003
2	Apolipoproteins E (ApoE)IBA 11/2021 - 12/2016
2	Nicotine FDA Link 01/2020 - 01/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2019 - 01/2016
2	Superoxide DismutaseIBA 11/2019 - 01/2016
2	candesartanIBA 01/2018 - 08/2002
2	erucylphosphocholineIBA 01/2018 - 12/2010
2	AlbuminsIBA 01/2018 - 07/2017
2	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 03/2017 - 02/2011
2	PNU-282987IBA 12/2016 - 01/2016
2	CC ChemokinesIBA 01/2016 - 01/2016
2	InflammasomesIBA 01/2016 - 01/2015
2	PotassiumIBA 01/2016 - 08/2003
2	Leptin ReceptorsIBA 01/2016 - 05/2011
2	HU 308IBA 01/2016 - 06/2015
2	Ethanol (Ethyl Alcohol)IBA 12/2015 - 07/2013
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2015 - 01/2011
2	Angiotensin-Converting Enzyme 2IBA 07/2014 - 01/2011
2	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2014 - 11/2012
2	VitaminsIBA 12/2011 - 02/2010
2	moxonidine (Moxon)IBA 02/2011 - 10/2007
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011 - 09/2008
2	Desoxycorticosterone Acetate (DOCA)FDA Link 12/2010 - 07/2005
2	Cholecalciferol (Vitamin D3)FDA Link 11/2010 - 11/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2009 - 01/2008
2	Atenolol (Tenormin)FDA LinkGeneric 04/2009 - 05/2004
1	LDL CholesterolIBA 11/2021
1	MT-1207IBA 06/2021
1	Neuroprotective AgentsIBA 01/2021
1	PC6 extract (PC6)IBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2019
1	Caspase 3 (Caspase-3)IBA 11/2019
1	ResveratrolIBA 05/2019

Therapy/Procedure

9	Denervation 12/2016 - 08/2002
4	Therapeutics 01/2020 - 11/2007
3	Ligation 09/2007 - 08/2003
1	Vagus Nerve Stimulation 01/2020
1	Transplantation 01/2020